NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.29+0.04 (+0.26%)
Close on Nov 18, 2026Market cap $1.98BP/E –Yield –
NeoGenomics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NeoGenomics's operating cash flow for the twelve months ending Sep 30, 2026 was $4.28M, down 68.7% year over year. For fiscal 2025 it was $5.23M, down 25.5% from the year before. Over ten years it grew -2.0% a year on average. The highest annual figure on record is $44.79M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.23M | -25.5% |
| FY2024 | Dec 31, 2024 | $7.02M | – |
| FY2023 | Dec 31, 2023 | -$1.95M | – |
| FY2022 | Dec 31, 2022 | -$65.99M | – |
| FY2021 | Dec 31, 2021 | -$26.72M | -1930.3% |
| FY2020 | Dec 31, 2020 | $1.46M | -93.8% |
| FY2019 | Dec 31, 2019 | $23.37M | -47.8% |
| FY2018 | Dec 31, 2018 | $44.79M | +148.3% |
| FY2017 | Dec 31, 2017 | $18.04M | -16.0% |
| FY2016 | Dec 31, 2016 | $21.48M | +235.9% |
| FY2015 | Dec 31, 2015 | $6.39M | -32.3% |
| FY2014 | Dec 31, 2014 | $9.45M | +324.3% |
| FY2013 | Dec 31, 2013 | $2.23M | – |
| FY2012 | Dec 31, 2012 | -$492.00K | -813.0% |
| FY2011 | Dec 31, 2011 | $69.00K | – |
| FY2010 | Dec 31, 2010 | -$2.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$8.89M | -200.0% |
| Q2 FY2026 | Jun 30, 2026 | $19.96M | -1.8% |
| Q1 FY2026 | Mar 31, 2026 | -$8.14M | – |
| Q4 FY2025 | Dec 31, 2025 | $1.34M | -86.3% |
| Q3 FY2025 | Sep 30, 2025 | $8.88M | -3.9% |
| Q2 FY2025 | Jun 30, 2025 | $20.33M | +46.3% |
| Q1 FY2025 | Mar 31, 2025 | -$25.33M | – |
| Q4 FY2024 | Dec 31, 2024 | $9.80M | -44.9% |
| Q3 FY2024 | Sep 30, 2024 | $9.25M | – |
| Q2 FY2024 | Jun 30, 2024 | $13.89M | – |
| Q1 FY2024 | Mar 31, 2024 | -$25.92M | – |
| Q4 FY2023 | Dec 31, 2023 | $17.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.50M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.69M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.69M | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.27M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.00M | – |
| Q1 FY2022 | Mar 31, 2022 | -$29.04M | -1414.0% |
| Q4 FY2021 | Dec 31, 2021 | -$19.78M | -430.4% |
| Q3 FY2021 | Sep 30, 2021 | -$7.77M | -1576.6% |
| Q2 FY2021 | Jun 30, 2021 | -$1.39M | -173.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.21M | – |
| Q4 FY2020 | Dec 31, 2020 | $5.99M | +78.2% |
| Q3 FY2020 | Sep 30, 2020 | $526.00K | -97.2% |
| Q2 FY2020 | Jun 30, 2020 | $1.88M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.93M | -213.7% |
| Q4 FY2019 | Dec 31, 2019 | $3.36M | -78.3% |
| Q3 FY2019 | Sep 30, 2019 | $18.63M | +122.3% |
| Q2 FY2019 | Jun 30, 2019 | -$4.72M | -171.1% |
| Q1 FY2019 | Mar 31, 2019 | $6.10M | -57.4% |
| Q4 FY2018 | Dec 31, 2018 | $15.45M | +168.3% |
| Q3 FY2018 | Sep 30, 2018 | $8.38M | +12.7% |
| Q2 FY2018 | Jun 30, 2018 | $6.64M | +1.7% |
| Q1 FY2018 | Mar 31, 2018 | $14.31M | – |
| Q4 FY2017 | Dec 31, 2017 | $5.76M | – |
| Q3 FY2017 | Sep 30, 2017 | $7.44M | – |
| Q2 FY2017 | Jun 30, 2017 | $6.53M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.69M | – |
| Q4 FY2016 | Dec 31, 2016 | -$241.00K | – |
See a number that looks wrong?